A Study to Assess Usability of Risankizumab Autoinjector Combination Product in Participants With Moderate to Severe Plaque Psoriasis

Condition:   Psoriasis Interventions:   Drug: Risankizumab;   Device: Autoinjector Sponsor:   AbbVie Not yet recruiting

Source: ClinicalTrials.gov - March 14, 2019 Category: Research Source Type: clinical trials